These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2591470)

  • 41. Release and absorption characteristics of novel theophylline sustained-release formulations: in vitro-in vivo correlation.
    Hussein Z; Friedman M
    Pharm Res; 1990 Nov; 7(11):1167-71. PubMed ID: 2293217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative study of the pharmacokinetic characteristics of slow release theophylline oral preparations in Thai children with persistent asthma.
    Trakultivakorn M; Kanthawatana S; Tontayapiwat A; Jiraporncharoen K
    Asian Pac J Allergy Immunol; 1999 Dec; 17(4):255-9. PubMed ID: 10698464
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the effect of different kinds of foods on the bioavailability of a sustained-release theophylline tablet.
    Gai MN; Thielemann AM; Arancibia A
    Int J Clin Pharmacol Ther Toxicol; 1993 Nov; 31(11):547-52. PubMed ID: 8294167
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetic analysis of sustained-release dosage forms of theophylline in humans: comparison of single and multiple dose studies.
    Hussein Z; Bialer M; Friedman M; Raz I
    Biopharm Drug Dispos; 1987; 8(5):427-35. PubMed ID: 3663879
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The rise and fall of serum theophylline concentration: a comparison of sustained-release formulations in volunteers with rapid theophylline clearance.
    Mucklow JC; Kuhn S
    Br J Clin Pharmacol; 1985 Dec; 20(6):589-96. PubMed ID: 4091990
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Absorption of theophylline from a sustained-release theophylline tablet formulation, Theo-Dur.
    Takagi K; Hasegawa T; Ogura Y; Yamaki K; Suzuki R; Satake T; Imaeda N; Mizukami Y
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):530-5. PubMed ID: 3429057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sustained-release theophylline pharmacokinetics in the cat.
    Dye JA; McKiernan BC; Jones SD; Neff-Davis CA; Koritz GD
    J Vet Pharmacol Ther; 1989 Jun; 12(2):133-40. PubMed ID: 2746720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bioavailability of two Soviet sustained-release theophylline formulations in comparison with TheoDur.
    Kiivet RA; Teder P; Pruunsild T; Svensson JO
    Pharmacol Toxicol; 1992 Nov; 71(5):388-90. PubMed ID: 1448452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of food on the bioavailability and pattern of release of a sustained-release theophylline tablet.
    Leeds NH; Gal P; Purohit AA; Walter JB
    J Clin Pharmacol; 1982 Apr; 22(4):196-200. PubMed ID: 7096605
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of moricizine on the pharmacokinetics of single-dose theophylline in healthy subjects.
    Pieniaszek HJ; Davidson AF; Benedek IH
    Ther Drug Monit; 1993 Jun; 15(3):199-203. PubMed ID: 8332999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetic profile of a new sustained-release theophylline pellet formulation for once-daily evening administration.
    Steinijans VW; Sauter R; Böhm A; Staudinger H
    Arzneimittelforschung; 1988 Aug; 38(8A):1241-50. PubMed ID: 3190813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Theophylline pharmacokinetics in children, comparing sustained release spheres (Theo-Dur sprinkle) with elixir.
    Kjellman NI; Croner S; Leijon I; Friberg K; Thuresson SO
    Eur J Pediatr; 1988 Dec; 148(3):278-80. PubMed ID: 3215203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Theophylline product and dosing interval selection for chronic asthma.
    Hendeles L; Weinberger M
    J Allergy Clin Immunol; 1985 Aug; 76(2 Pt 2):285-91. PubMed ID: 4019956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of once daily and twice daily sustained release theophylline formulations on daytime variation of bronchial hyperresponsiveness in asthmatic patients.
    Ferrari M; Olivieri M; Lampronti G; Bonazza L; Biasin C; Nacci P; Talamini G; Lo Cascio V
    Thorax; 1997 Nov; 52(11):969-74. PubMed ID: 9487345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sustained-release theophylline. Pharmacokinetic and therapeutic comparison of two preparations.
    Menendez R; Kelly HW; Howick J; McWilliams BC
    Am J Dis Child; 1983 May; 137(5):469-73. PubMed ID: 6846276
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The effect of food on theophylline absorption].
    Pabst G; Weber W; Müller M; Barkworth MF
    Arzneimittelforschung; 1998 May; 48(5A):569-73. PubMed ID: 9676346
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bioequivalence of a generic slow-release theophylline tablet in children.
    Kanthawatana S; Ahrens RC; McCubbin M; Bronsky E; Blake K; Hendeles L
    J Pediatr; 1994 Dec; 125(6 Pt 1):987-91. PubMed ID: 7996375
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
    Steinijans VW; Zech K; Fischer R
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of drug intake prior to or after meals on serum theophylline concentrations: single-dose studies with Euphylong.
    Schulz HU; Karlsson S; Sahner-Ahrens I; Steinijans VW; Beier W
    Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):222-8. PubMed ID: 3583472
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methods of comparing pharmacokinetics of slow release preparations: a comparison of "Theo-Dur" and "Phyllocontin" in patients with asthma.
    Jackson SH; Shah K; Turner P
    Eur J Clin Pharmacol; 1986; 30(3):313-7. PubMed ID: 3732367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.